Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
810 studies found for:    Open Studies | "Connective Tissue Diseases"
Show Display Options
Rank Status Study
21 Recruiting Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in MPS IIIB
Condition: Mucopolysaccharidosis IIIB
Intervention: Drug: SBC-103
22 Recruiting Study and Treatment of Inflammatory Muscle Diseases
Conditions: Autoimmune Disease;   Dermatomyositis;   Inclusion Body Myositis;   Myositis;   Polymyositis
Intervention:
23 Recruiting Biomarker for Morquio Disease
Conditions: Lysosomal Storage Diseases;   Morquio Disease
Intervention:
24 Recruiting Biomarker for Maroteaux-Lamy Disease
Conditions: Maroteaux-lamy Disease;   Lysosomal Storage Diseases
Intervention:
25 Recruiting Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Condition: Systemic Lupus Erythematosus
Interventions: Biological: BENLYSTA;   Other: SLE treatment
26 Unknown  Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease
Condition: Dupuytren's Contracture
Intervention: Drug: collagenase
27 Unknown  Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
Condition: Dupuytren's Contracture
Intervention: Drug: collagenase
28 Unknown  Ultraviolet Light Therapy for Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Procedure: ultraviolet A-1 light treatment
29 Unknown  Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis
Condition: Systemic Sclerosis
Intervention:
30 Unknown  Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients
Conditions: Pneumonia, Pneumocystis;   Prevention & Control
Intervention: Drug: Trimethoprim/Sulfamethoxazole
31 Unknown  Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Dehydroepiandrosterone (DHEA)
32 Unknown  Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients
Condition: Marfan Syndrome
Interventions: Drug: Losartan and nebivolol;   Drug: Losartan;   Drug: Nebivolol
33 Not yet recruiting Treatment of Exercise-induced Laryngomalacia in Elite Athletes
Condition: Exercise-induced Laryngomalacia
Interventions: Device: inspiratory muscle strength training;   Procedure: Surgery
34 Recruiting Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)
Condition: Rheumatoid Arthritis
Interventions: Drug: Sarilumab;   Drug: Tocilizumab
35 Unknown  Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin
Condition: Uterine Leiomyoma
Interventions: Drug: Dienogest;   Drug: Goserelin;   Drug: Desogestrel
36 Unknown  Metal Ions in Ceramic on Metal Total Hip Arthroplasty
Conditions: Osteoarthritis;   Avascular Necrosis;   Rheumatoid Arthritis;   Developmental Dysplasia of the Hip
Intervention:
37 Recruiting OTIS Autoimmune Diseases in Pregnancy Project
Conditions: Crohn's Disease;   Rheumatoid Arthritis
Intervention:
38 Unknown  Rituximab-induced Pulmonary Function Changes
Conditions: Rheumatoid Arthritis;   Inflammatory Myositis
Intervention: Other: Lung function measurement
39 Recruiting Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital
Condition: Cellulitis
Interventions: Other: Home;   Other: Ward;   Drug: ceftriaxone;   Drug: flucloxacillin
40 Not yet recruiting ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
Condition: Systemic Juvenile Idiopathic Arthritis (SJIA)
Intervention: Drug: ACZ885 150 mg (Canakinumab)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years